Ka lāʻau 'Atrovent'. i ke aʻo

E hoomakaukau ai "Atrovent" (inhalation) i 'ana bronhodillatiruyuschim hana. Ka lāʻau no hoi i ke kāohi ia, a no ka emi i ka secretion o bronchial glands a me ka pale bronchoconstriction.

O ia hoʻi, "Atrovent" alakai i ke heluhelu i hoakaka ia no ka maʻi obstructive pulmonary maʻi (me emphysema o na maʻiʻaʻai, obstructive bronchitis maʻi papa), e like me ka pono me ka bronchial asthma o ka meakino a me ka mehana.

Ka lapaʻauʻia contraindicated me hypersensitivity i na eiiiiiaiou, like hoʻi me ka ina o ka intolerance o atropine a me kona nā mea loaʻa.

Medicament "Atrovent" alakai i ke heluhelu e hoʻohana me ka mālama nui i loko o prostate hyperplasia, iaʻi ma ka urinary'āpana, huina-panina glaucoma, na keiki mai i ka makahiki eono, a i lactation a me ka hāpai keiki.

Adverse hoike ana mai o ka hoʻohana 'ana ai' nā gastrointestinal kāna hana (constipation a diarrhea, ka luaʻi 'ole nausea), maloo waha, headache.

Ka lāʻau "Atrovent" hiki no hoi i urinary ka mālama, noho kāna hana, palpitations, atrial fibrillation, supraventricular tachycardia, mahuahua naau kōmi. Eia naʻe i makemake ai adverse reactions malama i ka pohihihi keia hihia, a i ka hapanui reversible. Ma nā mea maʻi me ka obstructive lesions ma ka urinary'āpana maoli i ka pilikia o urinary ka mālama.

Hikiʻaoʻao hoike ia ia iho ia ka hoʻohana 'ana ai' "Atrovent" aʻo i cough, kūloko mea ukiuki loa, laryngospasm, angioedema, ili poʻe noʻonoʻoʻole, haanou ana o ke alelo, maka, lehelehe, hives, anaphylactic reactions. I ka pohihihi keia hihia oe i ka mahina bronchospasm.

Ka lāʻau "Atrovent". Na Ke Kumu no ka hoʻohana

Ka laʻau heluna regimen no kēlā me kēia hoomanawanui E e pākahi kau. Ma ka Inc o nā mea maʻi e kiai hoʻomalu.

E like me ka malama iapaau ana no nā mākua (me ka kūpuna), a me nā mea maʻi mua o ka umikumamalua makahiki paipai e mau mililika (kanaha kulu - 500 mcg) i ka lā, ekolu eha paha manawa. ʻO kā mākou dala o ka lāʻau no lā - 8 ml (2 mg).

Children mai eono a hiki i umikumamalua makahiki o ka lapaau "Atrovent" alakai ia kekahi i kekahi mililika me (20 kulu - 250 mcg) i ka lā, ekolu eha paha manawa. Hoʻomanawanui iki mai elemakule 6 hōʻike ma 0.4-1 ml (ewalu i iwakalua kulu - 100-250 mg) i ka lā, ekolu eha paha manawa. Reserve laʻau heluna no lā - eha mililika (1 mg).

Ma ka iapaau ana o ka huʻi bronchospasm hoʻomanawanui iki mai no he umikumamalua makahiki (me ka poʻeʻelemākule) e waiho ma ka 2 ml (kanaha kulu - 500 mcg). Prior e stabilize i ke ahonui o ka kulana ae reassignments. Ka hele kauka nā pūʻulu nāʻanuʻu ma waena o ka hooponopono.

'Ae' ana i ka poʻe loaa beta2-agonists.

Ke paipai nui o ka lāʻau "Atrovent" nāu kekahi ma mua hoʻohana me Saline i ka buke o ka ekolu i eha ka pono, ninini ihola i loko o ka nebulizer a me ka inhalation hanaia.

Nāu i ka lapaau mea pono i kela manawa ma mua o ka hana. Ke koe pāʻoihana ma hope o inhalation E e nininiʻia.

Ke kaumaha ma muli o ka 'ano o ka nebulizer a me ka hana ana o ke kaʻina hana, ka laʻau heluna e ĸokoĸa ana nä pane.

Medicine "Atrovent" Ua ae no ka hoʻohana me kekahi mau nebulizers. Inā o oxygen ua hoʻohana 'ia ka centralized'ōnaehana, ke kahe ana paipai i 6-8 H / min.

Ma lapaʻau hana, i ka hana i ho'ākāka 'hoikeana o overdose i ua hōʻike'. Ma nānaina o ka kūloko ano o ka hoʻohana a me ka laula o ka pākōlea hopenaʻoi loa o ka ai ' "Atrovent", i ka ulu ana o kekahi meaʻaoʻao' ole i olelo lealea. Aia paha e nīnūnē systemic hoike ana (a me ka hoomahuahua i loko o ka naʻau ana, maloo waha).

Ma mua o ka hoʻohana 'ana i ka lāʻau "Atrovent" Pono e akahele ninaninau i ka hōʻuluʻulu manaʻo a me ka nīnau aku i ke kauka.